Macular degeneration (also called AMD, ARMD, or age-related macular degeneration) is an age related condition in which the most sensitive part of the retina, called the macula, starts to break down and lose its ability to create clear visual images. The macula is responsible for central vision-the part of our sight we use to read, drive and recognize faces. So although a person’s peripheral vision is left unaffected by AMD, the most important aspect of vision is lost. AMD is the leading cause of vision loss and blindness in Americans of ages 65 and older. Older people represent an increasingly larger percentage of the general population, and vision loss associated with macular degeneration is a growing problem. Macular degeneration can be classified as either dry (non-neovascular) or wet (neovascular). Neovascular refers to growth of new blood vessels in an area, such as the macula, where they are not supposed to be. The dry form of AMD is more common-about 85% to 90% of all cases of macular degeneration are the dry variety. There is as yet no outright cure for macular degeneration, but some treatments may delay its progression or even improve vision. There are no FDA-approved treatments for dry AMD, although nutritional intervention may be valuable in preventing its progression to the more advanced, wet form. For wet AMD, there are several FDA-approved drugs aimed at stopping abnormal blood vessel growth and vision loss from the disease. In some cases, laser treatment of the retina may be recommended.
Supplements: We do recommend O2 Supplements and lubricating drops to support oxygen flow to preserve the eyes.